Literature DB >> 17764932

Selection and characterization of human monoclonal antibodies against Abrin by phage display.

Heyue Zhou1, Bin Zhou, Hongzheng Ma, Charlotte Carney, Kim D Janda.   

Abstract

Abrin is a highly potent and lethal type II ribosome inactivating toxin that may be used as a biological warfare agent. To date, no human anti-Abrin antibodies have yet to be reported. Herein, we describe the selection and characterization of two human monoclonal antibodies, termed E12 and RF12, which are capable of binding native Abrin with high affinity and specificity. Through surface plasmon resonance studies, we have determined the association and dissociation rate constants and the cross-reactivity for both antibodies. In our developed Biacore-based Abrin detection system, the limit of detection of antibodies E12 and RF12 is 35 and 75 ng/mL, respectively. These concentrations are about 5 x 10(4)-fold lower than the extrapolated Abrin human LD(50). In sum, our data demonstrated the power of human antibody phage display libraries and the promise of these antibodies as detection devices for Abrin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764932     DOI: 10.1016/j.bmcl.2007.07.053

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype B.

Authors:  Heyue Zhou; Bin Zhou; Sabine Pellett; Eric A Johnson; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2008-12-24       Impact factor: 2.823

2.  A Monoclonal-Monoclonal Antibody Based Capture ELISA for Abrin.

Authors:  Christina C Tam; Luisa W Cheng; Xiaohua He; Paul Merrill; David Hodge; Larry H Stanker
Journal:  Toxins (Basel)       Date:  2017-10-18       Impact factor: 4.546

3.  Llama-derived single domain antibodies specific for Abrus agglutinin.

Authors:  Ellen R Goldman; George P Anderson; Dan Zabetakis; Scott Walper; Jinny L Liu; Rachael Bernstein; Alena Calm; James P Carney; Thomas W O'Brien; Jennifer L Walker; Eric A E Garber
Journal:  Toxins (Basel)       Date:  2011-11-11       Impact factor: 4.546

4.  Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication.

Authors:  Adva Mechaly; Ron Alcalay; Tal Noy-Porat; Eyal Epstein; Yoav Gal; Ohad Mazor
Journal:  Toxins (Basel)       Date:  2018-02-13       Impact factor: 4.546

5.  Influence of Food Matrices on the Stability and Bioavailability of Abrin.

Authors:  Christina C Tam; Thomas D Henderson; Larry H Stanker; Luisa W Cheng
Journal:  Toxins (Basel)       Date:  2018-12-01       Impact factor: 4.546

Review 6.  Emergent Biosensing Technologies Based on Fluorescence Spectroscopy and Surface Plasmon Resonance.

Authors:  Alessandra Camarca; Antonio Varriale; Alessandro Capo; Angela Pennacchio; Alessia Calabrese; Cristina Giannattasio; Carlos Murillo Almuzara; Sabato D'Auria; Maria Staiano
Journal:  Sensors (Basel)       Date:  2021-01-29       Impact factor: 3.576

7.  Differentiation, Quantification and Identification of Abrin and Abrus precatorius Agglutinin.

Authors:  Sylvia Worbs; Bettina Kampa; Martin Skiba; Eva-Maria Hansbauer; Daniel Stern; Hervé Volland; François Becher; Stéphanie Simon; Martin B Dorner; Brigitte G Dorner
Journal:  Toxins (Basel)       Date:  2021-04-18       Impact factor: 4.546

8.  Toxin detection by surface plasmon resonance.

Authors:  Vesna Hodnik; Gregor Anderluh
Journal:  Sensors (Basel)       Date:  2009-02-26       Impact factor: 3.576

9.  Abrin Toxicity and Bioavailability after Temperature and pH Treatment.

Authors:  Christina C Tam; Thomas D Henderson; Larry H Stanker; Xiaohua He; Luisa W Cheng
Journal:  Toxins (Basel)       Date:  2017-10-13       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.